A secondary analysis of the TECOS trial affirms sitagliptin does not increase heart failure risk for patients with type 2 diabetes.
Read More »Stenting Risks For Insulin-Treated Diabetes Patients
Insulin may not be the culprit in poorer outcomes, according to TUXEDO sub-study.
Read More »SBP Level May Be Key to Setting Blood Pressure Treatment Goals for Diabetes
New meta analysis suggests overly aggressive goals may increase cardio risk for patients with systolic blood pressure below 140 mm Hg.
Read More »Can a Common Diabetes Drug Help Heart Attack Recovery?
Better understanding of drug’s mechanism of action can lead the way to new treatment options for heart disease in diabetes patients.
Read More »Severe Hypoglycemia in Type 2 Diabetes Linked to Progression of Coronary Artery Disease
Patients treated with standard therapy for blood glucose control show link between serious hypoglycemia and CAC progression, increasing risk of heart attack and stroke.
Read More »Bromocriptine-QR for Prevention of Cardiovascular Events in Type 2 Diabetes
Bromocriptine-QR may reduce CVD risk in type 2 patients independent of its effect on glycemic control.
Read More »How Low is Too Low? Blood Pressure Goals for Diabetic Patients
Research indicates setting more aggressive blood pressure goals for diabetic patients may cause harm.
Read More »Dr. George Bakris Part 1, Blood Pressure Guidelines
In part 1 of this exclusive video, DIC publisher Steve Freed once again visits with Dr. George Bakris to discuss the many blood pressure guidelines and what they should be for adults and those with diabetes.
Read More »Does Niacin Cause Diabetes?
Studies focus on whether niacin therapy and new-onset diabetes link is coincidence or something more.
Read More »Extreme Exercise
A professional society looks into how much physical activity is good for a healthy lifestyle.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.